Amgen Inc
Pharmaceutical & Health Products · Lobbying Client
B
Influence Score
63/100
High Influence
$17.1M
Total Lobby Spend
4
Policy Issues
6
Lobbyists
3
Revolving Door
Amgen Inc reported $17.1 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 4 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Dept of Commerce
Federal Communications Commission
US Trade Representative
Dept of Agriculture
Securities & Exchange Commission
Centers for Medicare & Medicaid Services
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | Brownstein Hyatt LLP | HCRPHAGOV | 2 | $727K |
| 2020 Apr-Jun | BGR Group LLP | HCR | 2 | $1.1M |
| 2020 Jul-Sep | Covington & Burling LLP | GOVMED | 2 | $820K |
| 2020 Oct-Dec | Brownstein Hyatt LLP | HCRMEDGOV+1 | 2 | $1.1M |
| 2021 Jan-Mar | Squire Patton Boggs LLP | PHAMEDGOV+1 | 3 | $1.0M |
| 2021 Apr-Jun | Covington & Burling LLP | HCRGOV | 1 | $1.1M |
| 2021 Jul-Sep | Cassidy & Associates LLP | GOVHCR | 1 | $987K |
| 2021 Oct-Dec | Brownstein Hyatt LLP | HCRPHA | 4 | $984K |